value spreadsheet

Post on 02-Jun-2018

215 views

Category:

Documents

0 download

Embed Size (px)

TRANSCRIPT

  • 8/10/2019 Value Spreadsheet

    1/58

    Name Arvind Remedies

    Industry Pharmaceuticals

    Market Cap (Cr) 318.15

    Exchange BSE

    Sr. No. Competitor Price EPS PE ratio1 100 10 10234567891011

    12

    1314151617181920

    Average 10

    100

    96100

    Result ReasonablePrice Based on PBV ratio

    Current

    Current

    CurrCurrent

    Price Based on PE ratio

    Price Based on PS ratio

  • 8/10/2019 Value Spreadsheet

    2/58

    20010 20

    8 2510 20

    Sales, Cr. Shares, Cr Sales / Share PS ratio BV / share PBV Ratio100 12 8.3 12 10 10

    12 10

    ales/share

    BV/share

    Current PS ratio

    Current PBV ratio

    nt EPS arket Price

    Current PE ratio

  • 8/10/2019 Value Spreadsheet

    3/58

    Ticker AAPL

    Company infoNameIndustry

    Market Cap (Cr)Exchange

    Score

    75 out of 100 $272P/E Valuation

    Fundamentals Judgement Points WeightReturn on Equity Good 9.09 5 Average estimateDebt/Equity Good 9.09 5 The estimate is

    Conservative PEG ratio Good 1.82 1 Current share priceP/E ratio Good 3.64 2 UndervaluedNet margin Good 5.45 3 Max purchase priceBookvalue per share Good 9.09 5Growth rate next 5yr Relatively low 0.00 1FCF yield Low 0.00 1Asset turnover change Good 7.27 4Current ratio Bad 0.00 5Altman Z Score Bad 0.00 3Accrual profit Reasonable 5.45 3

    Defensive profit Positive & increasing 5.45 3Enterprising profit Bad 0.00 4

    Debt Repayment Period Good 18.18 10 Tutorials:55 Support:

    Creation date:

    1. Click File > Make a copy.. to get your own version of this spreadsheet

    Arvind RemediesPharmaceuticals

    $318BSE

    Intrinsic value estimates

    Price info

    8/31/2014 10:33:00

  • 8/10/2019 Value Spreadsheet

    4/58

  • 8/10/2019 Value Spreadsheet

    5/58

    ##### #####DCF Valuation ROE Valuation

    $143,818Reasonable

    $47.00305895%

    $88,928.00

    http://www.valuespreadsheet.com/tutorialssupport@valuespreadsheet.com

  • 8/10/2019 Value Spreadsheet

    6/58

  • 8/10/2019 Value Spreadsheet

    7/58

  • 8/10/2019 Value Spreadsheet

    8/58

  • 8/10/2019 Value Spreadsheet

    9/58

  • 8/10/2019 Value Spreadsheet

    10/58

  • 8/10/2019 Value Spreadsheet

    11/58

  • 8/10/2019 Value Spreadsheet

    12/58

  • 8/10/2019 Value Spreadsheet

    13/58

  • 8/10/2019 Value Spreadsheet

    14/58

    In Millions of USD (except for per share items)

    52 weeks ending

    2013-09-28

    52 weeks ending

    2012-09-29

    Revenue 911.11 664.26Other Revenue, Total 0.47 0.59Total Revenue 911.57 664.85

    Cost of Revenue, Total 702.51 509.38Gross Profit 209.06 155.47Selling/General/Admin. Expenses, Total 0 0Research & Development 0 0Depreciation/Amortization 13.9 12.59Interest Expense(Income) - Net Operating 0 0Unusual Expense (Income) - -Other Operating Expenses, Total 31.66 21.15Total Operating Expense 45.56 33.74Operating Income 163.5 121.73

    Interest Income(Expense), Net Non-Operating 77.1 59.19Gain (Loss) on Sale of Assets - -Other, Net - -Income Before Tax 86.4 62.54Income After Tax 58.84 40.62Minority Interest - -Equity In Affiliates - -Net Income Before Extra. Items 58.84 40.62Accounting Change 0.06 0Discontinued Operations - -

    Extraordinary Item - -Net Income 58.9 40.62

    Preferred Dividends - -Income Available to Common Excl. Extra Items 58.9 40.62Income Available to Common Incl. Extra Items 58.9 40.62Basic Weighted Average Shares 4 3Basic EPS Excluding Extraordinary Items 8.65 8.42Basic EPS Including Extraordinary Items 8.65 8.42Dilution Adjustment 0 -Diluted Weighted Average Shares 4.3498 2.5639Diluted EPS Excluding Extraordinary Items 8.65 8.42

    Diluted EPS Including Extraordinary Items - -

    Dividends per Share - Common Stock Primary Issue - -

    Gross Dividends - Common Stock - -Net Income after Stock Based Comp. Expense - -Basic EPS after Stock Based Comp. Expense - -Diluted EPS after Stock Based Comp. Expense - -

    Depreciation, Supplemental - -Total Special Items - -

    Normalized Income Before Taxes - -Effect of Special Items on Income Taxes - -Income Taxes Ex. Impact of Special Items - -

    Income statement

  • 8/10/2019 Value Spreadsheet

    15/58

    Normalized Income After Taxes - -Normalized Income Avail to Common - -Basic Normalized EPS - -Diluted Normalized EPS 8.65 8.42

  • 8/10/2019 Value Spreadsheet

    16/58

    52 weeks ending

    2011-09-24

    52 weeks ending

    2010-09-25

    In Millions of USD (except for per share

    items)

    436.63 362.55 Cash & Equivalents0.39 0.34 Short Term Investments

    437.02 362.9 Cash and Short Term Investments

    351.15 311.99 Accounts Receivable - Trade, Net85.87 50.91 Receivables - Other

    0 0 Total Receivables, Net0 0 Total Inventory

    3.24 2.43 Prepaid Expenses0 0 Other Current Assets, Total

    - - Total Current Assets17.69 9.31 Property/Plant/Equipment, Total - Gross20.93 11.74 Accumulated Depreciation, Total64.94 39.17 Goodwill, Net

    27.72 16.39 Intangibles, Net- - Long Term Investments- - Other Long Term Assets, Total

    37.22 22.78 Total Assets19.41 16.89 Accounts Payable

    - - Accrued Expenses- - Notes Payable/Short Term Debt

    19.41 16.89 Current Port. of LT Debt/Capital Leases0 0.02 Other Current liabilities, Total

    - - Total Current Liabilities

    - - Long Term Debt19.41 16.9 Capital Lease Obligations

    - - Total Long Term Debt19.41 16.9 Total Debt19.41 16.9 Deferred Income Tax

    27 26 Minority Interest0.4 0.35 Other Liabilities, Total0.4 0.35 Total Liabilities

    - - Redeemable Preferred Stock, Total26.8918 26.0865 Preferred Stock - Non Redeemable, Net

    0.4 0.35 Common Stock, Total

    - - Additional Paid-In Capital

    - - Retained Earnings (Accumulated Deficit)

    - - Treasury Stock - Common- - Other Equity, Total- - Total Equity- - Total Liabilities & Shareholders' Equity

    - - Shares Outs - Common Stock Primary Issue- - Total Common Shares Outstanding

    - -- -- -

    Balance sheet

  • 8/10/2019 Value Spreadsheet

    17/58

    - -- -- -

    0.4 0.35

  • 8/10/2019 Value Spreadsheet

    18/58

    As of 2013-09-28 As of 2012-09-29 As of 2011-09-24 As of 2010-09-25

    23.7 21.95 13.81 7.24165.04 29.69 31.52 35.3188.74 51.64 45.33 42.54

    241.53 169.88 134.54 106.540 0 0 0

    241.53 169.88 134.54 106.54121.13 87.72 57.11 45.71

    - - - -165.04 29.69 24.54 27.46386.36 279.55 205.46 159.49277.77 258.07 57.98 48.02

    26.92 15.64 13.22 12.060 0 0 0

    4179 4224 3536 342106215 92122 55618 25391

    5146 5478 3556 2263207000 176064 116371 75183

    22367 21175 14632 120154782 3283 2428 1593

    0 0 0 0- - - -

    16509 14084 10910 711443658 38542 27970 20722

    16960 - - -- - - -

    16960 0 0 016960 0 0 016489 13847 8159 4300

    - - - -6344 5465 3627 2370

    83451 57854 39756 27392- - - -- - - -

    19764 16422 13331 10668

    - - - -

    104256 101289 62841 37169

    - - - --191 731 130 171

    123549 118210 76615 47791207000 176064 116371 75183

    - - - -6294.37 6574.46 6504.94 6411.79

  • 8/10/2019 Value Spreadsheet

    19/58

  • 8/10/2019 Value Spreadsheet

    20/58

    In Millions of USD (except for per

    share items)

    52 weeks ending

    2013-09-28

    52 weeks ending

    2012-09-29

    52 weeks ending

    2011-09-24

    Net Income/Starting Line 37037 41733 25922Depreciation/Depletion 6757 3277 1814Amortization - - -

    Deferred Taxes 1141 4405 2868Non-Cash Items 2253 1740 1168Changes in Working Capital 6478 -299 5757Cash from Operating Activities 53666 50856 37529Capital Expenditures -9076 -9402 -7452Other Investing Cash Flow Items, Total -24698 -38825 -32967Cash from Investing Activities -33774 -48227 -40419Financing Cash Flow Items -381 125 613Total Cash Dividends Paid -10564 -2488 0Issuance (Retirement) of Stock, Net -22330 665 831

    Issuance (Retirement) of Debt, Net 16896 - -Cash from Financing Activities -16379 -1698 1444Foreign Exchange Effects - - -Net Change in Cash 3513 931 -1446Cash Interest Paid, Supplemental - - -Cash Taxes Paid, Supplemental 9128 7682 3338

    Cash flow statement

  • 8/10/2019 Value Spreadsheet

    21/58

  • 8/10/2019 Value Spreadsheet

    22/58

    52 weeks ending

    2010-09-25

    140131027

    -

    1440903

    121218595-2121

    -11733-13854

    345-

    912

    -1257

    -5998

    -2697

  • 8/10/2019 Value Spreadsheet

    23/58

  • 8/10/2019 Value Spreadsheet

    24/58

    20% annualy

    25%9%

    5%12

    $47.00

    $ 10.052.13%

    0.9431.00%21.00%27.56%

    4.35

    $24$13

    $0

    Enterprise Value $17,254.45

    Month AVG P/E PRICE/ SALES PRICE/ BOOKNET PROFITMARGIN (%)

    9/4/2014 54.6 1.8 3.0 3.39/5/2014 34.4 3.3 6.0 9.69/6/2014 34.0 3.5 6.6 10.3

    9/7/2014 39.1 5.7 9.2 14.69/8/2014 21.2 3.2 4.5 14.99/9/2014 20.4 3.9 5.3 19.2

    9/10/2014 18.7 4.0 5.4 21.59/11/2014 13.8 3.3 4.6 23.99/12/2014 15.1 4.0 5.3 26.79/13/2014 12.0 2.6 3.5 21.7

    Conservatism inputsDesired return on investmentMargin of SafetyDiscount rate

    Growth decline rateYear 10 FCF multiplier

    Valuation inputsPriceEPSDividend YieldCurrent ratioPast 5 years EPS growth per year

    Capital Expenditures

    There is a known bug with the dates i